| 1 |
ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.
38
|
Tirosh A...Kebebew E
|
30865533
|
2019 |
| 2 |
Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule on GOT1 tumor in nude mice.
38
|
Spetz J...Forssell-Aronsson E
|
30895393
|
2019 |
| 3 |
Small Intestine Neuroendocrine Tumor in a Patient With MUTYH Adenomatous Polyposis-Case Report and SEER Analysis.
38
|
Weidner TK...Mishra N
|
29843990
|
2018 |
| 4 |
Prognostic Utility of 24-Hour Urinary 5-HIAA Doubling Time in Patients With Neuroendocrine Tumors.
38
|
Tirosh A...Kebebew E
|
30084688
|
2018 |
| 5 |
Time-dependent transcriptional response of GOT1 human small intestine neuroendocrine tumor after 177Lu[Lu]-octreotate therapy.
38
|
Spetz J...Forssell-Aronsson E
|
29502008
|
2018 |
| 6 |
Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor.
38
|
Montelius M...Forssell-Aronsson E
|
29331677
|
2018 |
| 7 |
Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.
38
|
Kharade SS...Agarwal SK
|
29309627
|
2018 |
| 8 |
Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.
38
|
Dalmo J...Forssell-Aronsson E
|
28097640
|
2017 |
| 9 |
Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.
38
|
Du Y...Kulke MH
|
27492634
|
2016 |
| 10 |
Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
38
|
Sadowski SM...Kebebew E
|
26350374
|
2015 |
| 11 |
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
38
|
Drozdov I...Modlin IM
|
19634160
|
2009 |
